Article
The P2X7 receptor in leukemia: pathological mechanisms and therapeutic potential.
Purinergic signalling - 1 Dec 2025
Xue Yanwen, Peng Xiaoxiang, Yan Meng, Du Yanan, Cao Yahui, Zhao Ronglan
Abstract excerpt
The P2X7 receptor is a trimeric ion channel purinergic receptor. It plays a crucial part in the pathophysiology of cancers and a variety of inflammatory diseases and is widely expressed in different cell types. Leukemia represents a type of malignant clonal disorder that impacts the hematopoietic stem cells. Chemotherapy is one of the main treatment methods for leukemia, but there are also many side effects. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
